Gvoke

About Xeris Biopharma

Xeris Biopharma is a commercial-stage company focused on transforming drug delivery through its proprietary formulation platforms, XeriSol™ and XeriJect™, which enable stable, ready-to-use injectables. Its strategy is anchored by the commercial success of Gvoke® (glucagon) for severe hypoglycemia and a pipeline targeting neurology and cardiology. The company aims to improve patient care by eliminating reconstitution, enabling home administration, and reducing healthcare system burdens through its innovative delivery solutions.

Therapeutic Areas